Oh no, you're thinking, yet another cookie pop-up. Well, sorry, it's the law. We measure how many people read us, and ensure you see relevant ads, by storing cookies on your device. If you're cool with that, hit “Accept all Cookies”. For more info and to customize your settings, hit “Customize Settings”.

Review and manage your consent

Here's an overview of our use of cookies, similar technologies and how to manage them. You can also change your choices at any time, by hitting the “Your Consent Options” link on the site's footer.

Manage Cookie Preferences
  • These cookies are strictly necessary so that you can navigate the site as normal and use all features. Without these cookies we cannot provide you with the service that you expect.

  • These cookies are used to make advertising messages more relevant to you. They perform functions like preventing the same ad from continuously reappearing, ensuring that ads are properly displayed for advertisers, and in some cases selecting advertisements that are based on your interests.

  • These cookies collect information in aggregate form to help us understand how our websites are being used. They allow us to count visits and traffic sources so that we can measure and improve the performance of our sites. If people say no to these cookies, we do not know how many people have visited and we cannot monitor performance.

See also our Cookie policy and Privacy policy.

This article is more than 1 year old

Wireless-controlled contraception implant is coming, says MIT

I love you baby, but we can't do it without encryption

MIT's decade-plus pitch to embed microchip-based drug-dispensaries in humans has been re-framed as a microprocessor-based, wireless-controlled, fully Internet-of-Things-compliant, implantable contraceptive.

Since 1999, MIT's Robert Langer et al have been pitching the idea of using microchips to deliver medicines. The idea, way back then, was envisaged chips with reservoirs of drugs kept behind a gold membrane. Applying a voltage to the membrane would dissolve it to release the liquid.

Perhaps because healthcare is one of the world's most regulated research fields, it took from 1999 to 2006 for MicroCHIPS (the company set up to commercialise the technology and manage the patent portfolio) to get through its pre-clinical work, according to the Boston Business Journal.

That was followed up with its first clinical trial, which was completed in 2012, testing dispensing osteoarthritis medications.

Along the way, it seems, the original gold membrane has been replaced by a titanium-platinum seal that operates on the same principle.

MIT's house magazine says the idea of using it for chip-borne contraceptives was sparked by a visit by Bill Gates to Langer's laboratory. The complaint that they're trying to address is that "contraception is inconvenient and imperfect".

The company claims a contraceptive chip could hold enough drug to last 16 years. In-built wireless communications would let women turn off contraception at will.

The company hasn't yet filed an application with the US Food and Drug Administration (FDA) to start tests. There's also no encryption for the chips' wireless communications.

And in spite of the device being widely welcomed as "imminent", MicroCHIPS's product pipeline doesn't even consider the contraceptive implant as in the preclinical stage yet. ®

 

Similar topics

TIP US OFF

Send us news


Other stories you might like